TNFSF13B and acute lymphoblastic leukemia: For example, AS605240, a selective PI3Kγ inhibitor, was assessed in several T-ALL cancer cell lines (CCRF-CEM, HPB-ALL, JURKAT, MOLT-4, PI2-ICHIKAWA, ALL-SIL, and TALL-1), and in lymphoblasts derived from patients with T-ALL [30].